JP2011068692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011068692A5 JP2011068692A5 JP2011000499A JP2011000499A JP2011068692A5 JP 2011068692 A5 JP2011068692 A5 JP 2011068692A5 JP 2011000499 A JP2011000499 A JP 2011000499A JP 2011000499 A JP2011000499 A JP 2011000499A JP 2011068692 A5 JP2011068692 A5 JP 2011068692A5
- Authority
- JP
- Japan
- Prior art keywords
- stomach food
- day
- rihaya
- diisopropylaminoethyl
- relaxant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011000499A JP5360075B2 (ja) | 2002-04-08 | 2011-01-05 | 胃食物受容能障害治療薬 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002104894 | 2002-04-08 | ||
| JP2002104894 | 2002-04-08 | ||
| JP2011000499A JP5360075B2 (ja) | 2002-04-08 | 2011-01-05 | 胃食物受容能障害治療薬 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581777A Division JP5281226B2 (ja) | 2002-04-08 | 2003-04-08 | 胃食物受容能障害治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011068692A JP2011068692A (ja) | 2011-04-07 |
| JP2011068692A5 true JP2011068692A5 (OSRAM) | 2012-08-09 |
| JP5360075B2 JP5360075B2 (ja) | 2013-12-04 |
Family
ID=28786350
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581777A Expired - Lifetime JP5281226B2 (ja) | 2002-04-08 | 2003-04-08 | 胃食物受容能障害治療薬 |
| JP2011000499A Expired - Lifetime JP5360075B2 (ja) | 2002-04-08 | 2011-01-05 | 胃食物受容能障害治療薬 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003581777A Expired - Lifetime JP5281226B2 (ja) | 2002-04-08 | 2003-04-08 | 胃食物受容能障害治療薬 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20050176788A1 (OSRAM) |
| EP (2) | EP2301540A1 (OSRAM) |
| JP (2) | JP5281226B2 (OSRAM) |
| KR (4) | KR20050002925A (OSRAM) |
| CN (2) | CN102125551B (OSRAM) |
| AT (1) | ATE522214T1 (OSRAM) |
| AU (1) | AU2003236326B2 (OSRAM) |
| CA (1) | CA2481916C (OSRAM) |
| CY (1) | CY1112057T1 (OSRAM) |
| DK (1) | DK1493441T3 (OSRAM) |
| ES (1) | ES2368732T3 (OSRAM) |
| PT (1) | PT1493441E (OSRAM) |
| SI (1) | SI1493441T1 (OSRAM) |
| WO (1) | WO2003084537A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447612A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 阿考替胺水合物晶型及其制备方法和用途 |
| CN103980226A (zh) * | 2014-05-10 | 2014-08-13 | 杭州新博思生物医药有限公司 | 盐酸阿考替胺水合物晶型及其制备方法 |
| CN105315225A (zh) * | 2014-07-07 | 2016-02-10 | 中美华世通生物医药科技（武汉）有限公司 | 阿考替胺的酸加成盐及其制备方法 |
| CN104045606B (zh) * | 2014-07-11 | 2015-09-30 | 杭州新博思生物医药有限公司 | 一锅法制备阿考替胺盐酸盐的方法 |
| CN109988121B (zh) * | 2019-04-28 | 2023-01-03 | 梯尔希（南京）药物研发有限公司 | 一种阿考替胺衍生物的制备方法 |
| US12202844B2 (en) | 2021-07-14 | 2025-01-21 | Blueprint Medicines Corporation | MAP4K1 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU699008B2 (en) * | 1995-05-18 | 1998-11-19 | Zeria Pharmaceutical Co., Ltd. | Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound |
| JPH10212271A (ja) * | 1997-01-31 | 1998-08-11 | Zeria Pharmaceut Co Ltd | Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体 |
| CA2293361C (en) * | 1997-06-24 | 2006-06-20 | Zeria Pharmaceutical Co., Ltd. | Process for producing 2-hydroxybenzamide derivatives |
| US5981556A (en) * | 1997-07-22 | 1999-11-09 | G.D. Searle & Co. | 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors |
| EP1135130A1 (en) * | 1998-11-23 | 2001-09-26 | Janssen Pharmaceutica N.V. | Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia |
| PL198552B1 (pl) * | 1999-06-02 | 2008-06-30 | Janssen Pharmaceutica Nv | Pochodna benzopiranu podstawionego aminoalkilem i sposób jej otrzymywania oraz kompozycja farmaceutyczna i sposób jej otrzymywania |
| WO2001037824A1 (en) * | 1999-11-23 | 2001-05-31 | Janssen Pharmaceutica N.V. | Use of 5ht3 agonists for relaxing the fundus |
| GB0002336D0 (en) * | 2000-02-01 | 2000-03-22 | Glaxo Group Ltd | Medicaments |
| DE60124117T8 (de) * | 2000-09-08 | 2007-05-31 | Zeria Pharmaceutical Co., Ltd. | Aminothiazol-derivate enthaltende pharmazeutische zusammensetzungen zur behandlung von motorischen störungen des kolons |
| US6986882B2 (en) * | 2002-01-17 | 2006-01-17 | Astrazeneca Ab | Therapy for functional dyspepsia |
-
2003
- 2003-04-08 SI SI200332073T patent/SI1493441T1/sl unknown
- 2003-04-08 ES ES03745958T patent/ES2368732T3/es not_active Expired - Lifetime
- 2003-04-08 KR KR10-2004-7015764A patent/KR20050002925A/ko not_active Ceased
- 2003-04-08 CN CN201010611741.5A patent/CN102125551B/zh not_active Expired - Lifetime
- 2003-04-08 AT AT03745958T patent/ATE522214T1/de active
- 2003-04-08 US US10/509,335 patent/US20050176788A1/en not_active Abandoned
- 2003-04-08 DK DK03745958.3T patent/DK1493441T3/da active
- 2003-04-08 CN CNA038079755A patent/CN1646123A/zh active Pending
- 2003-04-08 KR KR1020137022604A patent/KR101423284B1/ko not_active Expired - Lifetime
- 2003-04-08 EP EP10010621A patent/EP2301540A1/en not_active Withdrawn
- 2003-04-08 JP JP2003581777A patent/JP5281226B2/ja not_active Expired - Lifetime
- 2003-04-08 CA CA2481916A patent/CA2481916C/en not_active Expired - Lifetime
- 2003-04-08 WO PCT/JP2003/004445 patent/WO2003084537A1/ja not_active Ceased
- 2003-04-08 EP EP03745958A patent/EP1493441B1/en not_active Expired - Lifetime
- 2003-04-08 PT PT03745958T patent/PT1493441E/pt unknown
- 2003-04-08 KR KR1020117000220A patent/KR20110010837A/ko not_active Ceased
- 2003-04-08 AU AU2003236326A patent/AU2003236326B2/en not_active Expired
- 2003-04-08 KR KR1020127005319A patent/KR20120037035A/ko not_active Ceased
-
2009
- 2009-02-17 US US12/372,234 patent/US20090156652A1/en not_active Abandoned
-
2011
- 2011-01-05 JP JP2011000499A patent/JP5360075B2/ja not_active Expired - Lifetime
- 2011-11-16 CY CY20111101103T patent/CY1112057T1/el unknown
-
2014
- 2014-12-22 US US14/579,102 patent/US20150141475A1/en not_active Abandoned
-
2020
- 2020-08-20 US US16/998,637 patent/US20200375954A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013520405A5 (OSRAM) | ||
| JP2011068692A5 (OSRAM) | ||
| HRP20210343T1 (hr) | Soli ili ko-kristali 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola | |
| JP2011037901A5 (OSRAM) | ||
| JP2012502885A5 (OSRAM) | ||
| EA201490014A1 (ru) | Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот | |
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| JP2011201907A5 (OSRAM) | ||
| JP2012255026A5 (OSRAM) | ||
| JP2013534248A5 (OSRAM) | ||
| JP2015515475A5 (OSRAM) | ||
| JP2014515013A5 (OSRAM) | ||
| JP2010536849A5 (OSRAM) | ||
| JP2009537554A5 (OSRAM) | ||
| HRP20161577T1 (hr) | Inhibitori replikacije virusa gripe | |
| JP2012502037A5 (OSRAM) | ||
| JP2012533546A5 (OSRAM) | ||
| EA201390917A1 (ru) | Дигетероарильные соединения в качестве ингибиторов vps34 | |
| JP2014505107A5 (OSRAM) | ||
| IL292465B2 (en) | Neuroactive compounds and methods of use thereof | |
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2011219478A5 (OSRAM) | ||
| JP2014503593A5 (OSRAM) | ||
| WO2013057251A3 (en) | Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | |
| WO2012090225A3 (en) | Novel cocrystals / molecular salts of metformin with oleoylethanolamide as an effective anti-diabetic + anti- obesity agent |